ANKAR inhibitors represent a distinct class of chemical compounds that target specific protein-protein interactions within cellular signaling pathways. The name ANKAR is derived from the ankyrin repeat (ANK) domains, which are structural motifs commonly found in a variety of proteins. Ankyrin repeats are known for their role in mediating protein-protein interactions, as they form stacked helical arrays that create a stable interface for binding. ANKAR inhibitors are designed to disrupt these interactions by binding to the ankyrin repeats or their binding partners, thereby preventing the formation of larger protein complexes that rely on these domains for assembly or function. By interfering with the structural integrity of these complexes, ANKAR inhibitors can modulate key cellular processes such as signaling cascades, gene expression regulation, or cell cycle progression.
The chemical diversity of ANKAR inhibitors is wide, with structures ranging from small molecules to larger peptides or peptidomimetics, reflecting the versatility required to target different types of ankyrin repeat-containing proteins. These inhibitors often exploit specific hydrophobic or electrostatic interactions within the ankyrin repeat domains to achieve high specificity and affinity. In some cases, ANKAR inhibitors are designed to mimic the natural binding partners of ankyrin repeats, while in others, they take advantage of induced conformational changes that disrupt the structural stability of the repeat arrays. The ability of ANKAR inhibitors to selectively modulate protein-protein interactions at the molecular level makes them valuable tools for studying the functional roles of ankyrin repeat-containing proteins in cellular systems.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
A potent inhibitor of PI3K, wortmannin can suppress the PI3K/Akt signaling pathway, which can result in the downregulation of proteins involved in survival and proliferation. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
Another inhibitor of PI3K, LY294002 can prevent phosphorylation and activation of proteins downstream of the PI3K/Akt pathway. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
An inhibitor of mTOR, rapamycin can diminish the mTOR signaling that affects cell growth and metabolism, potentially influencing proteins regulated by this pathway. | ||||||
Triciribine | 35943-35-2 | sc-200661 sc-200661A | 1 mg 5 mg | $104.00 $141.00 | 14 | |
A specific Akt inhibitor, triciribine can block the activation of Akt and subsequently affect proteins that are modulated by Akt signaling. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
An MEK inhibitor, PD98059 can prevent the activation of the MAPK/ERK pathway, potentially affecting proteins that are phosphorylated by ERK. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
By inhibiting p38 MAPK, SB203580 can modulate inflammatory responses and influence proteins that are dependent on p38 MAPK signaling. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
An inhibitor of JNK, SP600125 can affect apoptosis and other cell processes regulated by the JNK signaling pathway. | ||||||
Bortezomib | 179324-69-7 | sc-217785 sc-217785A | 2.5 mg 25 mg | $135.00 $1085.00 | 115 | |
A proteasome inhibitor, bortezomib can disrupt the degradation of proteins, potentially causing an accumulation of proteins that are normally degraded. | ||||||
MG-132 [Z-Leu- Leu-Leu-CHO] | 133407-82-6 | sc-201270 sc-201270A sc-201270B | 5 mg 25 mg 100 mg | $60.00 $265.00 $1000.00 | 163 | |
Similar to bortezomib, MG132 can inhibit the proteasome and affect protein turnover, leading to altered protein levels. | ||||||
Cyclosporin A | 59865-13-3 | sc-3503 sc-3503-CW sc-3503A sc-3503B sc-3503C sc-3503D | 100 mg 100 mg 500 mg 10 g 25 g 100 g | $63.00 $92.00 $250.00 $485.00 $1035.00 $2141.00 | 69 | |
An immunosuppressant that can inhibit calcineurin, cyclosporin A can affect the NFAT signaling pathway and the proteins associated with it. | ||||||